Dispatches from EFSA plenary, Parma

We can't have both open doors and open discussions, says temp EFSA chair

The food industry has been portrayed as "the grand satan trying to poison the European community", says EFSA chair at plenary.

Transparency is important, but this may not be compatible with openness of scientific debate, according to the temporary chair of the European Food Safety Authority's (EFSA) Dietetic Products, Nutrition and Allergies (NDA) panel.

Talking at the EFSA base in Parma, Italy, panel chair Professor Sean Strain of Ulster University said that although he "sympathised" with the question of transparency, he thought truly open panels where members felt comfortable sharing information were only possible behind closed doors. In 2012, EFSA said it would open more of its Scientific Committee and Scientific Panel meetings to observers, as part of a push towards greater transparency and openness.

Strain also said a clear line must be drawn between scientific organisations like EFSA and policy makers and regulators. At an open-access EFSA plenary discussing transparency and scientific independence, he said he thought it was important to distinguish this clearly and saw examples of arguably blurred lines between science on paper and policy in practice as unhelpful. With institutions like the World Health Organisation (WHO), he said there was a"Chinese wall" between the scientists and the policy makers, with the two sometimes being the same thing.

He said to ensure scientific clarity, the scientific panel must "be blind to the needs of the industry and be blind to the needs of the consumer - this is in the remit of the Commission".

On the agenda 

Strain led the panel - made up of European scientists from a variety of backgrounds and disciplines - this week as the usual chair, Professor Ambroise Martin, was unable to attend. On Thursday, the nutrition panel discussed safe levels of caffeine, dietary reference values for folate and selenium and considered comments received during a period of public consultancy for a draft on the composition of milk-based drinks and products for infants and young children.

Wednesday was a day closed to the public due to the confidential, proprietary nature of the health claim applications discussed. Outlines of the claims and their applicants can be found here

Meanwhile on Friday - the second and last day open to press, firms, NGOs and trade associations - the panel is to discuss a dietary reference value for niacin including comments from a public consultancy and a draft opinion on health benefits of fish and shellfish consumption in relation to health risks associated to exposure to methylmercury.

Open panel = closed debate?

Strain said he thought some panel members - who may not be the principle researchers behind questions raised nor have English as their first language - may feel inhibited by having outsiders in the room.

He said it was important that "naive questions" were asked as this forced the expert panel members to go back and think about the fundamentals. More timid panelists may be reluctant to ask these 'in public', which could impact the advancements made in the discussion.

He added that it seemed certain NGOs and industry members were always "ready to jump on" any decision or statement made, which also risked keeping some panelists guarded.

Asked if the panel would ever be willing to record and upload open meetings, saving interested public the often long and complicated trip to Parma, Strain said he personally thought this would mean discussions would be "totally inhibited".

"I would have sympathy with transparency and open meetings, but I would be totally against recording."

Who's paying?

Among the observers was Dr Adriano Cattaneo for the breast milk lobby group International Baby Food Action Network (IBFAN), there to hear EFSA's reaction to public consultancy comments on infant and young children formula composition, for which it submitted feedback.

During a break for observer questions, Cattaneo asked how the panel had decided which DHA studies to include and if it considered industry-funded research to be intrinsically bias and therefore inappropriate to include.

This, Professor Strain replied, was not the place of the panel. Instead it assessed which research to include based on scientific and design merit alone.

Later, he added there had been a tendency towards a narrative with "industry as the grand satan trying to poison the European community".

"I don't know why the food industry is targeted more than pharma." 

He said just because research was funded by corporations, it didn't mean the science was wrong.

"Of course industry funds near to market. Private funding by its very nature could be leading research away from certain areas."

This, though, meant that more government-funded research was called for, he said, but did not detract from the findings of the industry-led studies. 

Related News

German nutrition board says it is relieved by EFSA's call on folate intake.

EFSA panel endorses draft dietary refs for folate, niacin and selenium

Is a human face what we really want from a scientific advisory board?

The EFSA experience – remits, scientific boxes and frustrated NGOs

“In the coming months, input from the public consultation will feed into finalisation of a new Open EFSA policy and follow-up plan.”

New EFSA chief commits to, ‘opening up its scientific processes’

EFSA wants your views on its openness...

EFSA extends consultation on ‘Open EFSA’

"It is entirely unjustified to imply lack of integrity of individual scientists that have accepted funding for their research programmes from industry and who have made appropriate declarations of funding sources," said Professor O'Rahilly

Scientists hit back over BMJ ‘links to industry’ claim

'I would actually change EFSA's role,' says Peter Wennström, president and consultant at The HealthyMarketingTeam

Industry heavy weights weigh in on EFSA and openness

Jones presented food industry concerns about data sharing at EFSA's transparency meeting this morning...

Industry concerned about data abuse as EFSA fans transparency wings

EFSA rejects ‘secret studies’ allegations

EFSA rejects ‘secret studies’ allegations

EFSA chiefs back independence amid transparency debate

EFSA chiefs: 'It is important EFSA understands the context of its scientific opinions'

NGO threatens EFSA with court action

Show us the documents: NGO threatens EFSA with court action

Dr Url: “I commit myself to working with staff, scientific experts, European institutions, member states and stakeholders to uphold EFSA’s core values and to work towards more open risk assessment and further building trust.”

EFSA confirms Bernard Url as new chief

EFSA to open more scientific meetings to observers

Comments (1)

Paul Clayton - 27 Jun 2014 | 05:24

Maginot Line

EFSA adjudicates on deckchair design while ignoring the iceberg we have already hit. The multis have created a toxic food universe, as reflected in our appalling public health stats; pathological omega 6/3 ratios, electrolyte ratios, nutrient density, insufficient prebiotics, excessive AGE / ALE compounds etc etc. If EFSA is not the solution, and it manifestly is not, then it is part of the problem. Good scientists often make lousy politicians, and EFSA exemplifies, sadly, regulatory capture.

27-Jun-2014 at 17:24 GMT

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.